School of Nursing, Peking University, Beijing, China.
Faculty of Education Science and Technology, Shanxi Datong University, Datong, Shanxi Province, China.
Fam Pract. 2021 Jul 28;38(4):537-542. doi: 10.1093/fampra/cmab004.
To examine the validity and reliability of the Mandarin version of the Treatment Burden Questionnaire (TBQ) among stroke patients.
Stroke patients need long-term management of symptoms and life situation, and treatment burden has recently emerged as a new concept that can influence the health outcomes during the rehabilitation process.
The convenience sampling method was used to recruit 187 cases of stroke patients in a tertiary grade hospital in Tianjin for a formal investigation. Item analysis, reliability and validity tests were carried out. The reliability test included internal consistency and test-retest reliability. And as well as content, structure and convergent validity were performed for the validity test.
Of the 187 completed questionnaires, only 180 (96.3%) were suitable for analysis. According to the experts' evaluation, the I-CVI of each item was from 0.833 to 1.000, and the S-CVI was 0.967. The exploratory factor analysis yielded three-factor components with a cumulative variation of 53.054%. Convergent validity was demonstrated using measures of Morisky's Medication Adherence Scale 8 (r = -0.450, P < 0.01). All correlations between items and global scores ranged from 0.403 to 0.638. Internal consistency reliability and test-retest reliability were found to be acceptable, as indicated by a Cronbach's α of 0.824 and an intraclass correlation coefficient of 0.846, respectively.
The Mandarin TBQ had acceptable validity and reliability. The use of TBQ in the assessment of treatment burden of stroke survivor may benefit health resources allocation and provide tailor therapeutic interventions to construct minimally disruptive care.
考察简体中文版治疗负担问卷（TBQ）在脑卒中患者中的有效性和信度。
脑卒中患者需要长期管理症状和生活状况，而治疗负担作为一个新的概念，最近已被证明会影响康复过程中的健康结果。
采用便利抽样法，在天津市某三级甲等医院招募 187 例脑卒中患者进行正式调查。进行项目分析、信度和效度检验。信度检验包括内部一致性和重测信度，而效度检验则包括内容、结构和聚合效度。
在完成的 187 份问卷中，仅有 180 份（96.3%）适合进行分析。根据专家评价，各条目 I-CVI 为 0.8331.000，S-CVI 为 0.967。探索性因子分析得出三因素结构，累计方差贡献率为 53.054%。采用 Morisky 用药依从性量表 8 项（r=-0.450，P<0.01）进行聚合效度验证。各条目与总量表之间的相关性在 0.4030.638 之间。内部一致性信度和重测信度可接受，Cronbach's α 为 0.824，组内相关系数为 0.846。
简体中文版 TBQ 具有良好的有效性和信度。在脑卒中患者治疗负担评估中使用 TBQ 可以有助于医疗资源的分配，并提供针对性的治疗干预措施，构建最小干扰的护理。
